
HealthcareClimate & EnergyBiotech & Life SciencesFintechE-Commerce & MarketplaceMobility & TransportationPropTech
Schooner Capital is a private investment firm and family office with a broad investment focus across various asset classes, including venture capital. Their strategy emphasizes a long-term, value-oriented approach, making direct investments in private companies and acting as a limited partner in venture capital funds.
Deal activity increased 200% year-over-year (3 deals in the last 12 months). Their most common stage is series-a (42% of deals). Average disclosed round size is $34.6M (across 12 rounds with reported amounts).
Portfolio
12
Fund Size
$300M
Top Stage
Series A
Last 12 Mo
3
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
12 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series A | $6.5M | Mar 2026 | |
| RRemedy Plan Therapeutics | Series A | $18M | May 2025 |
| Series B | $15M | May 2025 | |
| BBrixton Biosciences | Series B | $33M | May 2024 |
| Series B | $18M | Sep 2021 | |
| Series A | $84M | May 2020 | |
| Series C | $84M | May 2020 | |
| Series A | $115M | Jun 2019 | |
| MMaxwell Health | Series B | $26.4M | Dec 2014 |
| Seed | $4M | Apr 2012 | |
| ZZippity | Seed | $3M | — |
| Series A | $8M | — |
Top Co-Investors
Khosla Ventures3 shared
Breakthrough Energy Ventures3 shared
The Engine3 shared
Future Fund3 shared
Moore Strategic Ventures3 shared
Safar Partners3 shared
Starlight Ventures3 shared
Launch2 shared
Temasek Holdings2 shared
Equinor2 shared
Devonshire Investors2 shared
Eni Next2 shared
Health Catalyst Capital2 shared
First Round Capital1 shared
GV (Google Ventures)1 shared
NextView Ventures1 shared
Hostplus1 shared
Lowercase Capital1 shared
Adams Street1 shared
Vaizra Investments1 shared
Last updated: 15 April 2026